These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22005649)

  • 1. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
    Dvorak CC; Gracia CR; Sanders JE; Cheng EY; Baker KS; Pulsipher MA; Petryk A
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1725-38. PubMed ID: 22005649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid gland dysfunction, disorders of somatic and sexual development, disturbances of fertility after hematopoietic stem cell transplantation].
    Wędrychowicz A; Starzyk J
    Pediatr Endocrinol Diabetes Metab; 2013; 19(1):29-34. PubMed ID: 23739647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine complications of pediatric stem cell transplantation.
    Sklar C; Boulad F; Small T; Kernan N
    Front Biosci; 2001 Aug; 6():G17-22. PubMed ID: 11487479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
    Bhatia S; Davies SM; Scott Baker K; Pulsipher MA; Hansen JA
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1428-35. PubMed ID: 21763253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine complications of hematopoietic stem cell transplantation.
    Chemaitilly W; Sklar CA
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):983-98; ix. PubMed ID: 17983932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence.
    Jung MH; Cho KS; Lee JW; Chung NG; Cho B; Suh BK; Kim HK; Lee BC
    J Korean Med Sci; 2009 Dec; 24(6):1071-7. PubMed ID: 19949662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.
    Parsons SK; Phipps S; Sung L; Baker KS; Pulsipher MA; Ness KK
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):162-71. PubMed ID: 22155139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.
    Nieder ML; McDonald GB; Kida A; Hingorani S; Armenian SH; Cooke KR; Pulsipher MA; Baker KS
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1573-84. PubMed ID: 21963877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
    Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine late effects after hematopoietic stem cell transplantation.
    Roziakova L; Mladosievicova B
    Oncol Res; 2010; 18(11-12):607-15. PubMed ID: 20939437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
    Thomas-Teinturier C; Salenave S
    Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of some risk factors for abnormal growth velocity in children treated with haematopoetic stem cell transplantation].
    Wójcik D; Barg E; Niedzielska E; Doroszko A; Kałwak K; Pietras W
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):841-8. PubMed ID: 17317915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine late effects in children who underwent bone marrow transplantation: review.
    Cohen A; Rovelli R; Zecca S; Van-Lint MT; Parodi L; Grasso L; Uderzo C
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S64-7. PubMed ID: 9630330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.
    Barnum JL; Petryk A; Zhang L; DeFor TE; Baker KS; Steinberger J; Nathan B; Wagner JE; MacMillan ML
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1487-1492. PubMed ID: 27180116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution.
    Felicetti F; Manicone R; Corrias A; Manieri C; Biasin E; Bini I; Boccuzzi G; Brignardello E
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1343-8. PubMed ID: 21769505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults.
    Myers KC; Howell JC; Wallace G; Dandoy C; El-Bietar J; Lane A; Davies SM; Jodele S; Rose SR
    Bone Marrow Transplant; 2016 Jul; 51(7):980-4. PubMed ID: 26974276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late endocrine effects of childhood cancer treatment.
    Brougham MF; Kelnar CJ; Wallace WH
    Pediatr Rehabil; 2002; 5(4):191-201. PubMed ID: 12745898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010).
    Freycon F; Casagranda L; Trombert-Paviot B
    Pediatr Hematol Oncol; 2019 Mar; 36(2):86-102. PubMed ID: 30978121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.